샘플 요청 목록

 카트 문의
시장보고서
상품코드
1708029

세계의 의료용 임플란트 시장(2025-2032년) : 업계 분석, 규모, 점유율, 성장, 동향, 예측

Medical Implants Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
발행일: | 리서치사: Persistence Market Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 의료용 임플란트 시장 규모는 2025년에 1,216억 달러에 달할 것으로 예상되며, 2025-2032년의 예측 기간 동안 7.1%의 연평균 복합 성장률(CAGR)로 성장하여 2032년에는 1,964억 달러에 달할 것으로 예측되고 있습니다.

의료용 임플란트 시장에는 생체 구조와 기능을 대체, 지원 및 강화하기 위해 설계된 광범위한 장비가 포함되어 있습니다. 노인 인구 증가, 만성 질환의 유병률 증가 및 첨단 건강 관리 솔루션에 대한 의식이 증가함에 따라 의료용 임플란트 수요는 계속 급증하고 있습니다.

세계의 의료용 임플란트 시장의 성장은 여러 주요 요인에 의해 견인되고 있습니다. 또한, 생체적합성이 있는 금속, 세라믹, 폴리머 등의 생체재료의 기술 혁신에 의해 임플란트의 내구성과 성능이 향상하고 있습니다.

의료용 임플란트 시장은 큰 성장의 가능성이 있음에도 불구하고, 일부 저해 요인에 직면하고 있습니다. 임플란트 합병증은 환자의 예후를 악화시켜 보다 광범위한 보급을 방해할 수 있습니다. 또한 규제상의 과제와 새로운 임플란트 기술의 승인 절차에 시간이 걸리는 것도 시장의 혁신을 지연시킬 수 있습니다.

의료용 임플란트 시장에는 큰 기회가 존재합니다. 실시간 모니터링과 진단을 위한 스마트 테크놀로지와 센서를 임플란트와 통합하여 기술 혁신의 새로운 길을 개척할 수 있습니다. 3D 프린팅과 조직공학의 발전도 맞춤형 임플란트의 개발로 이어지면서 수술 결과를 향상시키고 있습니다. 아시아태평양과 라틴아메리카의 신흥 시장은 헬스케어 시스템의 개선, 의료 관광 확대, 질 높은 의료에 대한 수요 증가에 의해 수많은 성장의 가능성을 보유하고 있습니다. 또한, 임플란트 제조업체, 병원, 연구 기관의 전략적 제휴가 차세대 임플란트 솔루션의 채용을 촉진하고 있습니다.

본 보고서에서는 세계의 의료용 임플란트 시장에 대해 조사했으며, 제품 유형별, 생체재료 유형별, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

  • 시장의 범위와 정의
  • 시장 역학
  • 거시경제 요인
  • COVID-19의 영향 분석
  • 예측 요인 - 관련성과 영향

제3장 부가가치 인사이트

제4장 세계의 의료용 임플란트 시장 전망

  • 주요 하이라이트
  • 시장 규모의 분석과 예측
    • 과거 시장 규모(10억 달러) 분석(2019-2024년)
    • 현재 시장 규모의 분석과 예측(2025-2032년)
  • 세계의 의료용 임플란트 시장 전망 : 제품 유형별
    • 소개/주요 조사 결과
    • 과거 시장 규모(10억 달러) 분석, 제품 유형별(2019-2024년)
    • 현재 시장 규모(10억 달러) 분석과 예측, 제품 유형별(2025-2032년)
    • 시장의 매력 분석 : 제품 유형별
  • 세계의 의료용 임플란트 시장 전망 : 생체재료 유형별
    • 소개/주요 조사 결과
    • 과거 시장 규모(10억 달러) 분석, 생체재료 유형별(2019-2024년)
    • 현재 시장 규모(10억 달러) 분석과 예측, 생체재료 유형별(2025-2032년)
    • 시장의 매력 분석 : 생체재료 유형별

제5장 세계의 의료용 임플란트 시장 전망 : 지역별

  • 주요 하이라이트
  • 과거 시장 규모(10억 달러) 분석, 지역별(2019-2024년)
  • 현재 시장 규모(10억 달러) 분석과 예측, 지역별(2025-2032년)
    • 북미
    • 유럽
    • 동아시아
    • 남아시아와 오세아니아
    • 라틴아메리카
    • 중동 및 아프리카
  • 시장의 매력 분석 : 지역별

제6장 북미의 의료용 임플란트 시장 전망

제7장 유럽 의료용 임플란트 시장 전망

제8장 동아시아의 의료용 임플란트 시장 전망

제9장 남아시아 및 오세아니아의 의료용 임플란트 시장 전망

제10장 라틴아메리카의 의료용 임플란트 시장 전망

제11장 중동 및 아프리카의 의료용 임플란트 시장 전망

제12장 경쟁 구도

  • 시장 점유율 분석(2025년)
  • 시장의 제품 유형
  • 기업 프로파일(상세 - 개요, 재무, 전략, 최근 동향)
    • Johnson &Johnson Limited
    • Abbott Laboratories
    • Edwards Lifesciences Corporation
    • Orthofix International NV
    • Novartis International AG
    • Sorin SpA
    • Boston Scientific Corporation
    • Smith &Nephew plc
    • Tornier NV
    • Stryker Corporation

제13장 부록

CSM 25.04.25

Persistence Market Research has recently released a comprehensive report on the global Medical Implants Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Medical Implants Market Size (2025E): US$ 121.6 Bn
  • Projected Market Value (2032F): US$ 196.4 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 7.1%

Medical Implants Market - Report Scope:

The medical implants market includes a wide range of devices designed to replace, support, or enhance biological structures or functions. These implants are widely used in orthopedic, cardiovascular, dental, neurological, and cosmetic procedures. With a rising global geriatric population, increasing prevalence of chronic conditions, and growing awareness of advanced healthcare solutions, the demand for medical implants continues to surge. Technological advancements in biomaterials and minimally invasive surgeries further support the expansion of this market.

Market Growth Drivers:

The growth of the global medical implants market is driven by multiple key factors. The increasing prevalence of chronic diseases such as cardiovascular disorders, orthopedic conditions, and neurological issues has led to a rise in surgical interventions requiring implants. A rapidly aging population, especially in developed regions, is contributing significantly to the demand for orthopedic and cardiovascular implants. Moreover, technological innovations in biomaterials, such as biocompatible metals, ceramics, and polymers, have enhanced the durability and performance of implants. The growing trend of minimally invasive surgeries, combined with improved healthcare infrastructure and increased healthcare spending across emerging markets, also plays a pivotal role in driving market growth.

Market Restraints:

Despite strong growth potential, the medical implants market faces several restraints. High costs associated with implant procedures and devices can be a barrier to access, particularly in low- and middle-income countries. Additionally, complications related to implant rejection, infections, and device failures can pose risks to patient outcomes and deter wider adoption. Regulatory challenges and lengthy approval processes for new implant technologies may also hinder the market's pace of innovation. Furthermore, the lack of skilled professionals and inadequate awareness in certain regions can limit market penetration.

Market Opportunities:

Significant opportunities lie ahead for the medical implants market. The integration of smart technologies and sensors in implants for real-time monitoring and diagnostics is creating new avenues for innovation. Advancements in 3D printing and tissue engineering are enabling the development of customized implants tailored to individual patient anatomies, enhancing surgical outcomes. Emerging markets in Asia-Pacific and Latin America offer immense growth potential due to improving healthcare systems, expanding medical tourism, and rising demand for quality care. Additionally, strategic collaborations between implant manufacturers, hospitals, and research institutes can accelerate the adoption of next-generation implant solutions.

Key Questions Answered in the Report:

  • What are the primary factors driving the global medical implants market's growth?
  • Which product segments and regions are expected to experience the highest demand?
  • How are biomaterial innovations influencing the design and performance of medical implants?
  • Who are the major players in the medical implants market, and what strategies are they adopting to maintain a competitive edge?
  • What are the emerging trends shaping the future of the global medical implants market?

Competitive Intelligence and Business Strategy:

Leading companies in the global medical implants market, such as Johnson & Johnson Limited, Abbott Laboratories, and Boston Scientific Corporation, are focusing on technological innovation, expanding product portfolios, and investing in R&D to enhance implant functionality and patient outcomes. Strategic acquisitions, collaborations with healthcare providers, and expansion into emerging markets are common growth strategies. Companies are also prioritizing the development of bioresorbable and smart implants to meet the evolving needs of modern medicine. With a competitive landscape marked by rapid innovation and high investment in biocompatibility and sustainability, market players are working to strengthen their global footprint and brand reputation.

Companies Covered in This Report:

  • Johnson & Johnson Limited
  • Abbott Laboratories
  • Edwards Lifesciences Corporation
  • Orthofix International N.V.
  • Novartis International AG
  • Sorin S.p.A
  • Boston Scientific Corporation
  • Smith & Nephew plc
  • Tornier N.V.
  • Stryker Corporation

Market Segmentation:

By Product Type:

  • Orthopedic Implants
  • Cardiovascular Implants
  • Stents
  • Stent-related Implants
  • Structural Cardiac Implants
  • Spinal Implants
  • Neurostimulators
  • Ophthalmic Implants
  • Dental Implants
  • Facial Implants
  • Breast Implants

By Biomaterial Type:

  • Metallic Biomaterials
  • Ceramic Biomaterials
  • Polymers Biomaterials
  • Natural Biomaterials

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Medical Implants Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Product Adoption Analysis
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Global Medical Implants Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 4.3. Global Medical Implants Market Outlook: Product Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019-2024
    • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
      • 4.3.3.1. Orthopedic Implants
      • 4.3.3.2. Cardiovascular Implants
      • 4.3.3.3. Stents
      • 4.3.3.4. Stent-related Implants
      • 4.3.3.5. Structural Cardiac Implants
      • 4.3.3.6. Spinal Implants
      • 4.3.3.7. Neurostimulators
      • 4.3.3.8. Ophthalmic Implants
      • 4.3.3.9. Dental Implants
      • 4.3.3.10. Facial Implants
      • 4.3.3.11. Breast Implants
    • 4.3.4. Market Attractiveness Analysis: Product Type
  • 4.4. Global Medical Implants Market Outlook: Biomaterial Type
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Biomaterial Type, 2019-2024
    • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial Type, 2025-2032
      • 4.4.3.1. Metallic Biomaterials
      • 4.4.3.2. Ceramic Biomaterials
      • 4.4.3.3. Polymers Biomaterials
      • 4.4.3.4. Natural Biomaterials
    • 4.4.4. Market Attractiveness Analysis: Biomaterial Type

5. Global Medical Implants Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Medical Implants Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Product Type
    • 6.2.3. By Biomaterial Type
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 6.4.1. Orthopedic Implants
    • 6.4.2. Cardiovascular Implants
    • 6.4.3. Stents
    • 6.4.4. Stent-related Implants
    • 6.4.5. Structural Cardiac Implants
    • 6.4.6. Spinal Implants
    • 6.4.7. Neurostimulators
    • 6.4.8. Ophthalmic Implants
    • 6.4.9. Dental Implants
    • 6.4.10. Facial Implants
    • 6.4.11. Breast Implants
  • 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial Type, 2025-2032
    • 6.5.1. Metallic Biomaterials
    • 6.5.2. Ceramic Biomaterials
    • 6.5.3. Polymers Biomaterials
    • 6.5.4. Natural Biomaterials
  • 6.6. Market Attractiveness Analysis

7. Europe Medical Implants Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product Type
    • 7.2.3. By Biomaterial Type
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 7.4.1. Orthopedic Implants
    • 7.4.2. Cardiovascular Implants
    • 7.4.3. Stents
    • 7.4.4. Stent-related Implants
    • 7.4.5. Structural Cardiac Implants
    • 7.4.6. Spinal Implants
    • 7.4.7. Neurostimulators
    • 7.4.8. Ophthalmic Implants
    • 7.4.9. Dental Implants
    • 7.4.10. Facial Implants
    • 7.4.11. Breast Implants
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial Type, 2025-2032
    • 7.5.1. Metallic Biomaterials
    • 7.5.2. Ceramic Biomaterials
    • 7.5.3. Polymers Biomaterials
    • 7.5.4. Natural Biomaterials
  • 7.6. Market Attractiveness Analysis

8. East Asia Medical Implants Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product Type
    • 8.2.3. By Biomaterial Type
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 8.4.1. Orthopedic Implants
    • 8.4.2. Cardiovascular Implants
    • 8.4.3. Stents
    • 8.4.4. Stent-related Implants
    • 8.4.5. Structural Cardiac Implants
    • 8.4.6. Spinal Implants
    • 8.4.7. Neurostimulators
    • 8.4.8. Ophthalmic Implants
    • 8.4.9. Dental Implants
    • 8.4.10. Facial Implants
    • 8.4.11. Breast Implants
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial Type, 2025-2032
    • 8.5.1. Metallic Biomaterials
    • 8.5.2. Ceramic Biomaterials
    • 8.5.3. Polymers Biomaterials
    • 8.5.4. Natural Biomaterials
  • 8.6. Market Attractiveness Analysis

9. South Asia & Oceania Medical Implants Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product Type
    • 9.2.3. By Biomaterial Type
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 9.4.1. Orthopedic Implants
    • 9.4.2. Cardiovascular Implants
    • 9.4.3. Stents
    • 9.4.4. Stent-related Implants
    • 9.4.5. Structural Cardiac Implants
    • 9.4.6. Spinal Implants
    • 9.4.7. Neurostimulators
    • 9.4.8. Ophthalmic Implants
    • 9.4.9. Dental Implants
    • 9.4.10. Facial Implants
    • 9.4.11. Breast Implants
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial Type, 2025-2032
    • 9.5.1. Metallic Biomaterials
    • 9.5.2. Ceramic Biomaterials
    • 9.5.3. Polymers Biomaterials
    • 9.5.4. Natural Biomaterials
  • 9.6. Market Attractiveness Analysis

10. Latin America Medical Implants Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product Type
    • 10.2.3. By Biomaterial Type
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 10.4.1. Orthopedic Implants
    • 10.4.2. Cardiovascular Implants
    • 10.4.3. Stents
    • 10.4.4. Stent-related Implants
    • 10.4.5. Structural Cardiac Implants
    • 10.4.6. Spinal Implants
    • 10.4.7. Neurostimulators
    • 10.4.8. Ophthalmic Implants
    • 10.4.9. Dental Implants
    • 10.4.10. Facial Implants
    • 10.4.11. Breast Implants
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial Type, 2025-2032
    • 10.5.1. Metallic Biomaterials
    • 10.5.2. Ceramic Biomaterials
    • 10.5.3. Polymers Biomaterials
    • 10.5.4. Natural Biomaterials
  • 10.6. Market Attractiveness Analysis

11. Middle East & Africa Medical Implants Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product Type
    • 11.2.3. By Biomaterial Type
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 11.4.1. Orthopedic Implants
    • 11.4.2. Cardiovascular Implants
    • 11.4.3. Stents
    • 11.4.4. Stent-related Implants
    • 11.4.5. Structural Cardiac Implants
    • 11.4.6. Spinal Implants
    • 11.4.7. Neurostimulators
    • 11.4.8. Ophthalmic Implants
    • 11.4.9. Dental Implants
    • 11.4.10. Facial Implants
    • 11.4.11. Breast Implants
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial Type, 2025-2032
    • 11.5.1. Metallic Biomaterials
    • 11.5.2. Ceramic Biomaterials
    • 11.5.3. Polymers Biomaterials
    • 11.5.4. Natural Biomaterials
  • 11.6. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Product Type
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Johnson & Johnson Limited
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Abbott Laboratories
    • 12.3.3. Edwards Lifesciences Corporation
    • 12.3.4. Orthofix International N.V.
    • 12.3.5. Novartis International AG
    • 12.3.6. Sorin S.p.A
    • 12.3.7. Boston Scientific Corporation
    • 12.3.8. Smith & Nephew plc
    • 12.3.9. Tornier N.V.
    • 12.3.10. Stryker Corporation

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제